Skip to main content
Premium Trial:

Request an Annual Quote

Exiqon LNA Antisense Oligonucleotides

Exiqon's new Antisense LNA GapmeRs are now available for targeted inactivation of RNA in functional studies.

The oligonucleotides offer an alternative to existing siRNAs, allowing researchers to study the gene function and downstream biological consequences of silencing specific mRNAs or long non-coding RNAs in cell cultures or animal models.

The Scan

Push Toward Approval

The Wall Street Journal reports the US Food and Drug Administration is under pressure to grant full approval to SARS-CoV-2 vaccines.

Deer Exposure

About 40 percent of deer in a handful of US states carry antibodies to SARS-CoV-2, according to Nature News.

Millions But Not Enough

NPR reports the US is set to send 110 million SARS-CoV-2 vaccine doses abroad, but that billions are needed.

PNAS Papers on CRISPR-Edited Cancer Models, Multiple Sclerosis Neuroinflammation, Parasitic Wasps

In PNAS this week: gene-editing approach for developing cancer models, role of extracellular proteins in multiple sclerosis, and more.